Skip to main content

Anika Therapeutics, Inc.

ANIK
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000898437

In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Anika Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
127
−3 vs. Q3 2021
Shares held
13.5M
+338.9K (+2.6%) vs. Q3 2021
Total value
$483.3M
−$76.1M (−13.6%) vs. Q3 2021
New holders
11
42 more added
Sold out
14
49 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANIK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 127 institutions
Q1 2021: 146 institutionsQ2 2021: 139 institutionsQ3 2021: 131 institutionsQ4 2021: 127 institutionsQ1 2022: 119 institutionsQ2 2022: 126 institutionsQ3 2022: 123 institutionsQ4 2022: 125 institutionsQ1 2023: 121 institutionsQ2 2023: 117 institutionsQ3 2023: 117 institutionsQ4 2023: 117 institutionsQ1 2024: 120 institutionsQ2 2024: 114 institutionsQ3 2024: 122 institutionsQ4 2024: 109 institutionsQ1 2025: 108 institutionsQ2 2025: 104 institutionsQ3 2025: 117 institutionsQ4 2025: 126 institutionsQ1 2026: 130 institutionsQ2 2026: 133 institutions
Value heldQ4 2021: $483.3M
Q1 2021: $543.0MQ2 2021: $568.9MQ3 2021: $559.5MQ4 2021: $483.3MQ1 2022: $341.4MQ2 2022: $302.2MQ3 2022: $320.5MQ4 2022: $388.0MQ1 2023: $375.6MQ2 2023: $340.4MQ3 2023: $242.3MQ4 2023: $300.2MQ1 2024: $340.4MQ2 2024: $335.3MQ3 2024: $323.5MQ4 2024: $206.2MQ1 2025: $190.7MQ2 2025: $134.2MQ3 2025: $115.0MQ4 2025: $117.5MQ1 2026: $179.1MQ2 2026: $179.0M
Institutions holding ANIK and their total value by quarter
QuarterHoldersValue
Q2 2026133$179.0M
Q1 2026130$179.1M
Q4 2025126$117.5M
Q3 2025117$115.0M
Q2 2025104$134.2M
Q1 2025108$190.7M
Q4 2024109$206.2M
Q3 2024122$323.5M
Q2 2024114$335.3M
Q1 2024120$340.4M
Q4 2023117$300.2M
Q3 2023117$242.3M
Q2 2023117$340.4M
Q1 2023121$375.6M
Q4 2022125$388.0M
Q3 2022123$320.5M
Q2 2022126$302.2M
Q1 2022119$341.4M
Q4 2021127$483.3M
Q3 2021131$559.5M
Q2 2021139$568.9M
Q1 2021146$543.0M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Anika Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding ANIK in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Two Sigma Advisers, LP59,583$2.13M0.01%−4,200−6.6%Reduced
Nuveen Asset Management, LLC58,486$2.16M0.00%−3,785−6.1%Reduced
Franklin Resources Inc64,892$2.33M0.00%+17,500+36.9%Added
Fisher Asset Management, LLC70,587$2.53M0.00%+34,575+96.0%Added
Invesco Ltd.86,136$3.09M0.00%−3,661−4.1%Reduced
Charles Schwab Investment Management Inc101,570$3.64M0.00%+50.0%Added
Russell Investments Group, Ltd.107,464$3.85M0.01%−10,932−9.2%Reduced
Principal Financial Group Inc108,732$3.90M0.00%−5,646−4.9%Reduced
Ranger Investment Management, L.P.128,231$4.59M0.25%+120.0%Added
Assenagon Asset Management S.A.129,503$4.64M0.02%−140,618−52.1%Reduced
Bank of New York Mellon Corp132,259$4.74M0.00%−7,127−5.1%Reduced
Capital Management Corp132,850$4.76M0.99%+14,360+12.1%Added
D. E. Shaw & Co., Inc.161,675$5.79M0.01%−16,207−9.1%Reduced
Northern Trust Corp208,628$7.48M0.00%−9,334−4.3%Reduced
Geode Capital Management, LLC259,393$9.29M0.00%+730+0.3%Added
Fort Washington Investment Advisors Inc347,688$12.5M0.08%+31,810+10.1%Added
Janus Henderson Group PLC571,895$20.5M0.01%+108,110+23.3%Added
Trigran Investments, Inc.592,188$21.2M2.03%+165,595+38.8%Added
Renaissance Technologies LLC683,417$24.5M0.03%−20,600−2.9%Reduced
Morgan Stanley691,659$24.8M0.00%+125,813+22.2%Added
State Street Corp798,568$28.6M0.00%−12,806−1.6%Reduced
Dimensional Fund Advisors LP856,124$30.7M0.01%−5,809−0.7%Reduced
Vanguard Group Inc965,913$34.6M0.00%+13,535+1.4%Added
Ameriprise Financial Inc987,648$35.4M0.01%−7,309−0.7%Reduced
Kayne Anderson Rudnick Investment Management LLC1,466,763$52.6M0.12%+11,170+0.8%Added
BlackRock Inc.2,358,617$84.5M0.00%+46,837+2.0%Added
Sofos Investments, Inc.108––+104+2,600.0%Added
Citadel Advisors LLC0$00.00%−29,985−100.0%Sold out
Jackson Creek Investment Advisors LLC0$00.00%−24,764−100.0%Sold out
Bank of Montreal0$00.00%−21,390−100.0%Sold out
Jump Financial, LLC0$00.00%−11,200−100.0%Sold out
Marshall Wace, LLP0$00.00%−9,536−100.0%Sold out
HRT Financial LP0$00.00%−9,329−100.0%Sold out
Squarepoint Ops LLC0$00.00%−4,921−100.0%Sold out
Royce & Associates LP0$00.00%−4,809−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−1,310−100.0%Sold out
Simplex Trading, LLC0$00.00%−512−100.0%Sold out
First Quadrant L P0$00.00%−343−100.0%Sold out
Harbour Investments, Inc.0$00.00%−200−100.0%Sold out
Better Money Decisions, LLC0$00.00%−43−100.0%Sold out
Meeder Asset Management Inc0$00.00%−18−100.0%Sold out
BBVA USA––––Not filed